Glaucoma Trial, Recruiting NCT06952153 Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06952153
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 years or older
  • People who have a specific type of eye angle blockage (where the drainage angle of the eye is closed for more than half its circumference)
  • People diagnosed with glaucoma that has caused damage to the optic nerve along with loss of vision in parts of their visual field
  • People whose eye pressure remains above 21 mmHg (a unit used to measure eye pressure) even while using eye pressure-lowering medication
  • People who are able to give informed consent and attend all required follow-up appointments
  • People with a cataract rated as mild to moderate in severity (grades 1 to 3 on a standard clinical scale)
  • People whose best corrected vision (with glasses or contact lenses) is 20/40 or worse

Who may not be able to join:

  • People whose glaucoma is very advanced, with vision reduced to only being able to detect light
  • People whose angle-closure glaucoma is caused by another underlying condition
  • People who have had previous eye surgery or a specific laser procedure on the eye (laser peripheral iridotomy)
  • People with a known allergy to a medication called 5-fluorouracil (5-FU), which may be used after the procedure
  • People with a permanent, irreversible disease affecting the cornea (the clear front surface of the eye)
  • People who use corticosteroid (steroid) medications on an ongoing basis
  • People who are unlikely to be able to attend regular follow-up appointments
  • People with a cataract rated as severe (grades 4 or 5 on the standard clinical scale)
  • People with certain specific types of cataracts that are related to the lens causing complications within the eye, or where the lens is not sitting in its normal position

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 450390405

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
30 July 2027

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Mean change in intraocular pressure (IOP) from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov